TY - JOUR
T1 - Triangle of Trust in Cancer Care? The Physician, the Patient, and Artificial Intelligence Chatbot
AU - Turner, J. Harvey
PY - 2023
Y1 - 2023
N2 - Trust, as a philosophic paradigm, is predominantly interpersonal, between human beings, and is differentiated from reliance. Can a person trust an inhumane amoral agent, such as a large language model artificial intelligence (AI) chatbot, to manifest the goodwill and willingness normally required in order for it to be deemed trustworthy? This article explores the relationship between the cancer patient, their physician, and AI chatbot in a proposed tripartite, consultative, personalized approach to shared-care in precision molecular oncology. It examines the nature of trust between human agents and machines. It also contemplates AI-enhanced technical precision in state-of-the-art cancer management, complemented by trustworthy, holistic clinical care by a physician, for each individual patient.
AB - Trust, as a philosophic paradigm, is predominantly interpersonal, between human beings, and is differentiated from reliance. Can a person trust an inhumane amoral agent, such as a large language model artificial intelligence (AI) chatbot, to manifest the goodwill and willingness normally required in order for it to be deemed trustworthy? This article explores the relationship between the cancer patient, their physician, and AI chatbot in a proposed tripartite, consultative, personalized approach to shared-care in precision molecular oncology. It examines the nature of trust between human agents and machines. It also contemplates AI-enhanced technical precision in state-of-the-art cancer management, complemented by trustworthy, holistic clinical care by a physician, for each individual patient.
KW - phronesis
KW - precision versus personalized oncology
KW - shared-care
KW - trust in artificial intelligence
UR - http://www.scopus.com/inward/record.url?scp=85172093676&partnerID=8YFLogxK
U2 - 10.1089/cbr.2023.0112
DO - 10.1089/cbr.2023.0112
M3 - Editorial
C2 - 37707991
AN - SCOPUS:85172093676
SN - 1084-9785
VL - 38
SP - 581
EP - 584
JO - Cancer Biotherapy and Radiopharmaceuticals
JF - Cancer Biotherapy and Radiopharmaceuticals
IS - 9
ER -